GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Theravance Inc. (THRX) CEO Rick E Winningham sells 127,746 Shares

May 12, 2011 | About:
insider

insider

56 followers
CEO of Theravance Inc. (THRX) Rick E Winningham sells 127,746 shares of THRX on 05/11/2011 at an average price of $26.34 a share.

Theravance Inc. has a market cap of $2.17 billion; its shares were traded at around $26.22 with and P/S ratio of 89.6.

This is the annual revenues and earnings per share of THRX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of THRX.


CEO Recent Trades:



  • Sell: CEO Rick E Winningham sold 63,873 shares of THRX stock on 03/01/2011 at the average price of 22.53. Rick E Winningham owns at least 613,652 shares after this. The price of the stock has increased by 16.38% since.
  • Sell: CEO Rick E Winningham sold 252,300 shares of THRX stock on 02/28/2011 at the average price of 22.24. Rick E Winningham owns at least 677,525 shares after this. The price of the stock has increased by 17.9% since.
  • Sell: CEO Rick E Winningham sold 266,400 shares of THRX stock on 02/23/2011 at the average price of 21.35. Rick E Winningham owns at least 556,273 shares after this. The price of the stock has increased by 22.81% since.

CFO Recent Trades:



  • Sell: Sr VP, CFO Michael W Aguiar sold 10,000 shares of THRX stock on 12/03/2010 at the average price of 26.51. Michael W Aguiar owns at least 109,601 shares after this. The price of the stock has decreased by 1.09% since.

This is the insider trade history vs. stock price of THRX. For the complete insider trading history of THRX, click here.




Directors and Officers Recent Trades:



  • Buy: 10% Owner Plc Glaxosmithkline bought 261,299 shares of THRX stock on 05/03/2011 at the average price of 25.6. Plc Glaxosmithkline owns at least 6,163,577 shares after this. The price of the stock has increased by 2.42% since.
  • Buy: 10% Owner Plc Glaxosmithkline bought 152,278 shares of THRX stock on 02/18/2011 at the average price of 23.7. Plc Glaxosmithkline owns at least 5,902,278 shares after this. The price of the stock has increased by 10.63% since.
  • Buy: 10% Owner Plc Glaxosmithkline bought 5,750,000 shares of THRX stock on 11/29/2010 at the average price of 22.5. Plc Glaxosmithkline owns at least 5,750,000 shares after this. The price of the stock has increased by 16.53% since.
  • Sell: Head of Business Dev. David L Brinkley sold 47,592 shares of THRX stock on 03/16/2011 at the average price of 22.08. David L Brinkley owns at least 98,379 shares after this. The price of the stock has increased by 18.75% since.
  • Sell: Sr VP, Gen. Counsel, Secretary Bradford J Shafer sold 26,689 shares of THRX stock on 03/11/2011 at the average price of 22.76. Bradford J Shafer owns at least 349,575 shares after this. The price of the stock has increased by 15.2% since.


For the complete insider trading history of THRX, click here.

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 5.0/5 (1 vote)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide